You are here:Home-ADCs and PROTACs-PROTAC-SIAIS562055
SIAIS562055

Chemical Structure : SIAIS562055

CAS No.:

SIAIS562055 (SIAIS 562055)

Catalog No.: PC-23302Not For Human Use, Lab Use Only.

SIAIS562055 is a potent, selective SOS1 PROTAC degrader (KD=95.9 nM) which is designed by connecting a CRBN ligand to an analogue of the SOS1 inhibitor BI-3406, selectively degrades SOS1 with DC50 values of 62.5 nM and 8.4 nM in K562 and KU812 cells.

Packing Price Stock Quantity
25 mg Get quote
50 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

SIAIS562055 is a potent, selective SOS1 PROTAC degrader (KD=95.9 nM) which is designed by connecting a CRBN ligand to an analogue of the SOS1 inhibitor BI-3406, selectively degrades SOS1 with DC50 values of 62.5 nM and 8.4 nM in K562 and KU812 cells.
SIAIS562055 effectively blocks the binding of KRASG12C or KRASG12D to SOS1, with the IC50 values of 95.7 nM and 134.5 nM, respectively.
SIAIS562055 does not affect GSPT1 and IKZF1/3 protein level in MIA PaCa-2 cells.
SIAIS562055 inhibits ERK phosphorylation, suppresses the proliferation of BCR-ABL+ CML cells, inhibits the proliferation of K562 and KU812 cells, with IC50 values of 201.1 nM and 45.6 nM, respectively.
SIAIS562055 enhances the sensitivity of CML cell to BCR-ABL inhibitors by SLC22A4-mediated cellular uptake transport.
Combination of SIAIS562055 and imatinib exerts synergistic antitumor efficacy in mouse model and primary CML patient samples.

Physicochemical Properties

M.Wt 918.13
Formula C49H62F3N7O5S
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

3-(4-((12-(4-((4-(((R)-1-(3-amino-5-(trifluoromethyl)phenyl)ethyl)amino)-7-methoxy-2-methylquinazolin-6-yl)oxy)piperidin-1-yl)dodecyl)thio)-1-oxoisoindolin-2-yl)piperidine-2,6-dione

References

1. Luo Z, et al. Cancer Res. 2024 Oct 22. doi: 10.1158/0008-5472.CAN-24-1093.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: